Literature DB >> 25238605

Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study.

Yoshitaka Hashimoto1, Masahide Hamaguchi, Takao Kojima, Yasuhiro Ohshima, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura, Michiaki Fukui.   

Abstract

BACKGROUND AND AIM: Recent cross-sectional studies have been reported the possibility that light to moderate alcohol consumption might be negatively associated with fatty liver. However, there has been no large-scale longitudinal study addressing an impact of alcohol consumption on a development of fatty liver diagnosed by ultrasonography. Thus, we investigated the impact of alcohol consumption on a natural history of fatty liver.
METHODS: We analyzed 5437 apparently healthy Japanese who received the health checkup programs repeatedly over 10 years. In this study, we used a standardized questionnaire for addressing the medical history and lifestyle and used a standardized ultrasonographic diagnosis for fatty liver. The total amount of alcohol consumed per week was calculated and classified into four grades; none or minimal, light, moderate, or heavy alcohol consumption (< 40, 40-140, 140-280 or > 280 g/week, respectively). The hazard risks of alcohol consumption for the development of fatty liver were calculated by Cox hazard model after adjusting age, BMI, and parameters for lifestyle.
RESULTS: During 10 years of follow-up, fatty liver was continuously diagnosed just in 10% of men and 20% of women with fatty liver at the baseline. In men, the adjusted hazard risks of light and moderate alcohol consumption for the development of fatty liver were 0.72 (95% confidence interval 0.60-0.86, P < 0.001) and 0.69 (0.57-0.84, P < 0.001), respectively. However, they were not significant in women.
CONCLUSIONS: The newly onset of fatty liver was significantly repressed in apparently healthy men who consume light to moderate alcohol.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  NAFLD; epidemiology; fatty liver; obesity

Mesh:

Year:  2015        PMID: 25238605     DOI: 10.1111/jgh.12786

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  40 in total

1.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

2.  Is there a safe threshold for alcohol consumption in nonalcoholic fatty liver disease?

Authors:  Mimi Kim; Dae Won Jun
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 7.293

3.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

4.  Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-09-30       Impact factor: 3.633

5.  Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.

Authors:  Michelle T Long; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Timothy S Naimi
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-14       Impact factor: 11.382

Review 6.  Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations.

Authors:  Richard Parker; Seung-Jin Kim; Bin Gao
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

7.  Alcohol consumption in the general population is associated with structural changes in multiple organ systems.

Authors:  Hideaki Suzuki; Wenjia Bai; Evangelos Evangelou; Raha Pazoki; He Gao; Paul M Matthews; Paul Elliott
Journal:  Elife       Date:  2021-06-01       Impact factor: 8.713

8.  Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

Review 9.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

10.  Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.

Authors:  Xiaodan Zheng; Changchun Cao; Yongcheng He; Xinyu Wang; Jun Wu; Haofei Hu
Journal:  Lipids Health Dis       Date:  2021-06-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.